WO2007146965A3 - Compounds for the treatment of periodontal disease - Google Patents

Compounds for the treatment of periodontal disease Download PDF

Info

Publication number
WO2007146965A3
WO2007146965A3 PCT/US2007/071049 US2007071049W WO2007146965A3 WO 2007146965 A3 WO2007146965 A3 WO 2007146965A3 US 2007071049 W US2007071049 W US 2007071049W WO 2007146965 A3 WO2007146965 A3 WO 2007146965A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
treatment
periodontal disease
periodontal
disease
Prior art date
Application number
PCT/US2007/071049
Other languages
French (fr)
Other versions
WO2007146965A2 (en
Inventor
Virginia Sanders
Kirk R Maples
Jacob J Plattner
Carolyn Bellinger-Kawahara
Original Assignee
Anacor Pharmaceuticals Inc
Virginia Sanders
Kirk R Maples
Jacob J Plattner
Carolyn Bellinger-Kawahara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Virginia Sanders, Kirk R Maples, Jacob J Plattner, Carolyn Bellinger-Kawahara filed Critical Anacor Pharmaceuticals Inc
Priority to AU2007257689A priority Critical patent/AU2007257689A1/en
Priority to BRPI0713010-4A priority patent/BRPI0713010A2/en
Priority to EP07812123A priority patent/EP2044091A4/en
Priority to MX2008015918A priority patent/MX2008015918A/en
Priority to CA002654449A priority patent/CA2654449A1/en
Publication of WO2007146965A2 publication Critical patent/WO2007146965A2/en
Priority to IL195571A priority patent/IL195571A0/en
Publication of WO2007146965A3 publication Critical patent/WO2007146965A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

Compounds, compositions and methods are provided which are useful in the treatment of periodontal disease.
PCT/US2007/071049 2006-06-12 2007-06-12 Compounds for the treatment of periodontal disease WO2007146965A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2007257689A AU2007257689A1 (en) 2006-06-12 2007-06-12 Compounds for the treatment of periodontal disease
BRPI0713010-4A BRPI0713010A2 (en) 2006-06-12 2007-06-12 compounds for the treatment of periodontal disease
EP07812123A EP2044091A4 (en) 2006-06-12 2007-06-12 Compounds for the treatment of periodontal disease
MX2008015918A MX2008015918A (en) 2006-06-12 2007-06-12 Compounds for the treatment of periodontal disease.
CA002654449A CA2654449A1 (en) 2006-06-12 2007-06-12 Compounds for the treatment of periodontal disease
IL195571A IL195571A0 (en) 2006-06-12 2008-11-27 Compounds for the treatment of periodontal disease

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80450406P 2006-06-12 2006-06-12
US60/804,504 2006-06-12
US82389306P 2006-08-29 2006-08-29
US60/823,893 2006-08-29

Publications (2)

Publication Number Publication Date
WO2007146965A2 WO2007146965A2 (en) 2007-12-21
WO2007146965A3 true WO2007146965A3 (en) 2008-12-04

Family

ID=38832802

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/071049 WO2007146965A2 (en) 2006-06-12 2007-06-12 Compounds for the treatment of periodontal disease

Country Status (9)

Country Link
EP (1) EP2044091A4 (en)
KR (1) KR20090029797A (en)
AU (1) AU2007257689A1 (en)
BR (1) BRPI0713010A2 (en)
CA (1) CA2654449A1 (en)
IL (1) IL195571A0 (en)
MX (1) MX2008015918A (en)
RU (1) RU2008152367A (en)
WO (1) WO2007146965A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2343304T1 (en) 2005-02-16 2015-08-31 Anacor Pharmaceuticals, Inc. Biocidal boronophthalide compounds
AU2006333527B2 (en) 2005-12-30 2013-08-01 Anacor Pharmaceuticals, Llc Boron-containing small molecules
CA2642583C (en) * 2006-02-16 2016-08-23 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
JO3598B1 (en) * 2006-10-10 2020-07-05 Infinity Discovery Inc Boronic acids and esters as inhibitors of fatty acid amide hydrolase
JO3396B1 (en) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc Boron-containing small molecules
US8039450B2 (en) 2008-03-06 2011-10-18 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
AU2009233711B2 (en) 2008-04-09 2015-02-12 Infinity Pharmaceuticals, Inc Inhibitors of fatty acid amide hydrolase
US8853424B2 (en) 2008-08-11 2014-10-07 Japan Science And Technology Agency Protein cross-linking inhibitor
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010027975A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
MA32977B1 (en) 2008-12-17 2012-01-02 Anacor Pharmaceuticals Inc Polymorphic of (s) -3-aminomethyl-7-(3-hydroxy-propoxy) -3h-benzo (c (1,2) oxporol-1-ol
JP2012523424A (en) 2009-04-07 2012-10-04 インフイニトイ プハルマセウトイカルス インコーポレイテッド Inhibitors of fatty acid amide hydrolase
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
TW201109022A (en) * 2009-06-03 2011-03-16 Colgate Palmolive Co Borinic compositions
RU2012107163A (en) 2009-07-28 2013-09-10 Анакор Фармасьютикалз, Инк. TRIZED SUBSTITUTE BORN-CONTAINING MOLECULES
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
US9346834B2 (en) 2009-10-20 2016-05-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110212918A1 (en) 2009-11-11 2011-09-01 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011063293A1 (en) * 2009-11-20 2011-05-26 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antihelminth agents
RU2414210C1 (en) * 2009-12-28 2011-03-20 Общество С Ограниченной Ответственностью "Сплат-Косметика" (Ооо "Сплат-Косметика") Medication for removal of tobacco resins and based on it composition
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
BR112012019120A2 (en) 2010-02-03 2016-06-28 Infinity Pharmaceuticais Inc solid form, pharmaceutical composition, method of preparing compound 1, method of treating a faah-mediated condition
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
ES2898695T3 (en) 2010-09-07 2022-03-08 Anacor Pharmaceuticals Inc Benzoxaborole derivatives for the treatment of bacterial infections
AR088668A1 (en) * 2011-11-21 2014-06-25 Lilly Co Eli SMALL MOLECULES CONTAINING BORO
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
DK2950644T3 (en) 2013-01-30 2017-09-04 Agrofresh Inc USE OF BENZOXABOROLS AS VOLATIVE ANTIMICROBIAL AGENTS IN MEAT, PLANTS OR PARTS
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
KR20170024068A (en) 2014-07-01 2017-03-06 다이이찌 산쿄 가부시키가이샤 Tricyclic benzoxaboroles as antibacterial agents
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
RU2018142490A (en) * 2016-05-09 2020-06-10 Анакор Фармасьютикалз, Инк. CRYSTAL FORMS OF CRYZABOROL IN A FREE FORM AND METHOD FOR PRODUCING AND USING THEM
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
CN107759625B (en) * 2016-08-22 2020-12-29 药源药物化学（上海）有限公司 Preparation method of 4- (1-hydroxy-1, 3-dihydrobenzo [ c ] [1,2] oxaborole-5-yloxy) benzonitrile
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. Novel oxaborole analogs and uses thereof
EP3576747A4 (en) * 2017-03-09 2020-12-16 The Penn State Research Foundation Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase
CN110183477B (en) * 2019-07-03 2022-03-04 石家庄诚志永华显示材料有限公司 Organic electroluminescent compounds and use thereof
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna
KR102638321B1 (en) * 2022-01-27 2024-02-19 마이크로바이오헬스케어 주식회사 Novel compound with anti-biofilm formation activity and use of the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716035A (en) * 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US20050070503A1 (en) * 2002-12-18 2005-03-31 Ving Lee Antibiotics containing borinic acid complexes and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1155698A4 (en) * 1999-01-29 2003-01-15 Nitto Kasei Co Ltd Organoboron compounds exhibiting anticoccidial activities
CN101928295A (en) * 2002-12-18 2010-12-29 安那卡药品公司 Antibiotics containing borinic acid complexes and methods of use
US20070155698A1 (en) * 2003-09-02 2007-07-05 Doron Steinberg Oxazaborolidines as bacteria effectors
AR049916A1 (en) * 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc ANTI-PARASITARY USES OF BORINIC ACID COMPLEXES
AR049915A1 (en) * 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc COMPOUNDS WITH BORO CONTENT AND METHODS OF USE OF THE SAME

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716035A (en) * 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US20050070503A1 (en) * 2002-12-18 2005-03-31 Ving Lee Antibiotics containing borinic acid complexes and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BAILEY J. ET AL.: "Boron-Containing Antibacterial Agents: Effects on Growth and Morphology of Bacteria Under Various Culture Conditions", ANTIMICROBIAL AND AGENTS AND CHEMOTHERAPY, vol. 17, no. 4, April 1980 (1980-04-01), pages 549 - 553, XP002922581 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens

Also Published As

Publication number Publication date
IL195571A0 (en) 2009-09-01
WO2007146965A2 (en) 2007-12-21
MX2008015918A (en) 2009-01-14
AU2007257689A1 (en) 2007-12-21
CA2654449A1 (en) 2007-12-21
EP2044091A4 (en) 2010-08-04
KR20090029797A (en) 2009-03-23
BRPI0713010A2 (en) 2012-10-09
RU2008152367A (en) 2010-07-20
EP2044091A2 (en) 2009-04-08

Similar Documents

Publication Publication Date Title
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
HK1209729A1 (en) Compounds, compositions and methods
EP1868628A4 (en) Compounds, compositions and methods for the treatment of poxvirus infections
IL233634A0 (en) Methods, compositions, and kits for the treatment of medical conditions
EP1987141B8 (en) Compositions suitable for treating collagen-mediated diseases
WO2009129246A3 (en) Compositions and methods for preparing and using same
IL182837A0 (en) Methods, assays and compositions for treating retinol-related diseases
WO2008005705A3 (en) Metal-containing formulations and methods of use
AU2006279280A8 (en) Methods and compositions for treating neurological disease
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2008027600A3 (en) Imatinib compositions
WO2010059531A3 (en) Alpha-keto peracids and methods for producing and using the same
WO2007106436A3 (en) Photoactive compounds and compositions and uses thereof
EP1962852A4 (en) Compounds, compositions and methods
IL186127A (en) Pharmaceutical compositions for treating depression and methods for preparing the same
WO2008066630A3 (en) Methods for reprogramming adult somatic cells and uses thereof
WO2009071689A3 (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
GB0516245D0 (en) Process, composition and compound
WO2007071444A3 (en) Esomeprazole arginine
WO2008085927A3 (en) Methods, compositions, and kits for the treatment of pain
WO2005110391A3 (en) Compounds for treating human papillomavirus
AP2005003270A0 (en) Composition for the treatment of humans.
AU2005905768A0 (en) Therapeutic methods, compositions and kits
AU2005903111A0 (en) Combination Treatment
AU2004901220A0 (en) Compositions and methods for treatment disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812123

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2007257689

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 573095

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2654449

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10234/DELNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: MX/A/2008/015918

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007257689

Country of ref document: AU

Date of ref document: 20070612

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2007812123

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2008152367

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020097000565

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0713010

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20081212

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)